Therapeutic outcome in invasive aspergillosis

Clinical Infectious Diseases

Volumn 23, Issue 3, 1996, Pages 608-615

  Denning, David W ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ASPERGILLOSIS; BRAIN INFECTION; HUMAN; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; MORTALITY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REVIEW;

EID: 0029811772     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.3.608     Document Type: Review

References (11)

1. Fraser DW, Ward JI, Ajello L, Plikaytis BD. Aspergillosis and other systemic mycoses: the growing problem. JAMA 1979;242:1631-5.
2. Okudaira M, Kume H, Kurata H, Sakabe F. Recent statistical survey of visceral aspergillosis in Japan, and experimental studies on the pathogenicity of Aspergillus fumigatus in rabbits. Zentralbl Bakteriol Mikrobiol Hyg [A] 1986;261:529-38.
3. Groll A, Shah PM, Mentzel CH, Schneider M. Changing pattern of invasive mycoses at autopsy [abstract no J109]. In: Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (Orlando, Florida). Washington, DC: American Society for Microbiology, 1994:106.
4. Bodey G, Bueltmann B, Duguid W, et al. Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis 1992;11:99-109.
5. Kelmenson VA. Treatment of pulmonary aspergillosis. Dis Chest 1959;36:442-443.
6. Dupont B, Drouhet E. Early experience with itraconazole in vitro and in patients: pharmacokinetic studies and clinical results. Rev Infect Dis 1987;9(suppl 1):S71-6.
7. Mills W, Chopra R, Linch DC, Goldstone AH. Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients. Br J Haematol 1994;86:754-60.
8. Ng TTC, Denning DW. Liposomal amphotericin B (AmBisome) therapy of systemic fungal infections - evaluation of UK compassionate use data. Arch Intern Med 1995;155:1093-8.
9. Bowden RA, Cays M. Phase I study of amphotericin B colloidal dispersion (ABCD) for the treatment of invasive fungal infection after marrow transplant [abstract no 56]. In: Proceedings of Trends in Invasive Fungal Infections II (Manchester). 1993.
10. Walsh TJ, Hiemenz JW, Seibel N, Anaissie EJ. Amphotericin B lipid complex in the treatment of 228 cases of invasive mycosis [abstract no M69]. In: Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (Orlando, Florida). Washington, DC: American Society for Microbiology, 1994:247.
11. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990;12:1147-201.